Home / Inspections / 1316122

FDA Inspection 1316122 — Hanlim Pharm Co. Ltd.

Hanlim Pharm Co. Ltd. — FEI 3004886113

The FDA completed an inspection of Hanlim Pharm Co. Ltd. on April 10, 2026 in Yongin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 10, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Yongin (Korea (the Republic of))

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1313712 (OAI Fri Apr 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1171848 (VAI Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1039954 (OAI Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 985577 (VAI Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 879041 (VAI Fri Apr 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources